The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEkf Diagnostics Regulatory News (EKF)

Share Price Information for Ekf Diagnostics (EKF)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 27.60
Bid: 27.10
Ask: 28.90
Change: -0.20 (-0.72%)
Spread: 1.80 (6.642%)
Open: 27.60
High: 27.60
Low: 27.60
Prev. Close: 27.80
EKF Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

25 May 2016 12:47

RNS Number : 2919Z
EKF Diagnostics Holdings PLC
25 May 2016
 

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi

1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached: ii

EKF Diagnostics Holdings Plc

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

YES

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

An event changing the breakdown of voting rights

Other (please specify):

3. Full name of person(s) subject to thenotification obligation: iii

Harwood Capital LLP (as investment adviser/manager) and North Atlantic Smaller Companies Investment Trust plc

4. Full name of shareholder(s)  (if different from 3.):iv

1. North Atlantic Smaller Companies Investment Trust PLC

 

2. Oryx International Growth Fund Limited

 

 

5. Date of the transaction and date onwhich the threshold is crossed orreached: v

20 MAY 2016

6. Date on which issuer notified:

24 MAY 2016

7. Threshold(s) that is/are crossed orreached: vi, vii

ABOVE 19%

 

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

Numberof shares

Number of votingrights

% of voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

GB0031509804

 46,300,000

 

35,350,000

 

 

 

 

46,300,000

 

35,350,000

 

 

 

 

48,650,000

 

35,350,000

 

 

 

 

48,650,000

 

35,350,000

 

 

 

 

11.53%

 

8.38%

 

 

 

 

 

 

 

 

 

Holder 1:

 

Holder 2:

 

 

 

 

 

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Expirationdate xiii

Exercise/Conversion Period xiv

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

% of votingrights

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financialinstrument

Exercise price

Expiration date xvii

Exercise/Conversion period xviii

Number of voting rights instrument refers to

 

% of voting rights xix, xx

 

 

 

Nominal

Delta

Total (A+B+C)

Number of voting rights

Percentage of voting rights

84,00,000

19.90%

 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi

 

 

Proxy Voting:

10. Name of the proxy holder:

11. Number of voting rights proxy holder will ceaseto hold:

12. Date on which proxy holder will cease to holdvoting rights:

13. Additional information:

14. Contact name:

Jane Muir

15. Contact telephone number:

0200 8819 6486

 

 

 

 

 

 

 

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLUVSARNVAVUAR
Date   Source Headline
10th Dec 20157:00 amRNSDirectorate Changes
9th Dec 20154:46 pmRNSHolding(s) in Company
2nd Dec 20152:39 pmRNSDirectorate Changes
30th Nov 20155:39 pmRNSHolding(s) in Company
30th Nov 20157:00 amRNSDirectorate Changes
26th Nov 20157:00 amRNSTrading update
20th Nov 20152:55 pmRNSDeath of Director
12th Nov 20154:35 pmRNSPrice Monitoring Extension
12th Nov 20157:00 amRNSConsolidation of manufacturing sites
11th Nov 20157:00 amRNSDirectorate Change
9th Nov 20157:00 amRNSBiomarker data predicting diabetic kidney disease
6th Nov 20157:00 amRNSSelah consideration update
23rd Oct 20155:06 pmRNSStrategic Update
23rd Oct 20154:58 pmRNSOffer Talks Terminated
23rd Oct 201510:14 amPRNForm 8.3 - EKF Diagnostics Holdings Plc
22nd Oct 20152:37 pmRNSForm 8.3 - [EKF Diagnostics Holdings plc]
22nd Oct 20152:26 pmRNSForm 8.3 re Zwanziger Family re EKF Diagnostics
21st Oct 20154:46 pmRNSForm 8.3 re Zwanziger Family re EKF Diagnostics
19th Oct 201511:59 amRNSForm 8.3 - Zwanziger Family Ventures LLC
19th Oct 20157:00 amRNSExtension to deadline under Rule 2.6(c)
15th Oct 20157:00 amRNSPointMan used in liquid biopsy research study
13th Oct 20153:07 pmRNSForm 8.3 - [EKF Diagnostics Holdings plc]
12th Oct 201511:48 amRNSForm 8.3 - EKF Diagnostics Holdings plc
2nd Oct 201510:54 amPRNForm 8.3 - EKF Diagnostic Holdings Plc
1st Oct 20155:04 pmRNSForm 8.3 - EKF Diagnostics Holdings PLC
1st Oct 201510:10 amPRNForm 8.3 - EKF Diagnostics Holdings Plc
30th Sep 20151:18 pmRNSForm 8.3 - EKF Diagnostics Holdings plc
29th Sep 20151:33 pmRNSForm 8.3 - EKF Diagnostics Holdings plc
28th Sep 20157:00 amRNSHalf Yearly Report
24th Sep 20151:33 pmRNSForm 8.3 - EKF Diagnostics Holdings plc
24th Sep 201512:21 pmRNSForm 8.3-EKF Diagnostics Hldng PLC-Replacement
23rd Sep 20154:35 pmRNSForm 8.3 - EKF Diagnostics Holdings PLC
18th Sep 20157:00 amRNSNew data published on PointMan
18th Sep 20157:00 amRNSOffer Update
9th Sep 20157:00 amRNSForm 8.3 - EKF Diagnostics Holdings PLC
8th Sep 20159:39 amRNSWebsite Details for Company Announcements
7th Sep 20157:00 amRNSStatement Regarding EKF Diagnostics Holdings plc
7th Sep 20157:00 amRNSForm 8 (OPD) EKF Diagnostics Holdings plc
3rd Sep 20156:07 pmRNSForm 8.3 - EKF Diagnostics Holdings plc
3rd Sep 20157:00 amRNSNew tender wins for Hemo Control
2nd Sep 201510:54 amRNSForm 8 (OPD) (EKF Diagnostics Holdings plc)
28th Aug 201510:46 amRNSForm 8.3 - EKF Diagnostics Holdings plc
27th Aug 20151:22 pmRNSForm 8.3 - EKF Diagnostics Holdings plc
26th Aug 20154:27 pmRNSForm 8.3 - EKF Diagnostics Holdings plc
26th Aug 20154:27 pmRNSForm 8.3 - EKF Diagnostics Holdings plc
26th Aug 20158:03 amRNSWithdrawal of non-binding proposal
25th Aug 20153:00 pmRNSForm 8.3 - [EKF Diagnostics Holdings plc]
25th Aug 20152:58 pmRNSForm 8.3 - EKF Diagnostics Holdings plc
25th Aug 20152:36 pmBUSForm 8.3 - EKF Diagnostics Holdings Plc
25th Aug 20152:15 pmRNSForm 8.3 - EKF Diagnostics Holdings Plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.